Royal Bank of Canada’s Cryo-Cell International CCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-105
Closed 7166
2025
Q4
$0 Buy
+105
New +$436 ﹤0.01% 7198
2024
Q3
Sell
-121
Closed -$1K 6898
2024
Q2
$1K Buy
121
+47
+64% +$389 ﹤0.01% 6792
2024
Q1
$1K Sell
74
-29
-28% -$164 ﹤0.01% 6767
2023
Q4
$1K Buy
103
+102
+10,200% +$528 ﹤0.01% 6897
2023
Q3
$0 Sell
1
-51
-98% -$298 ﹤0.01% 7113
2023
Q2
$0 Buy
+52
New +$252 ﹤0.01% 7284
2022
Q4
Sell
-67
Closed 7258
2022
Q3
$0 Sell
67
-2,133
-97% -$13.1K ﹤0.01% 7471
2022
Q2
$13K Buy
+2,200
New +$14.1K ﹤0.01% 6264

Other funds holding CCEL

Royal Bank of Canada's CCEL Position: Q1 2026 in Review

Royal Bank of Canada sold out of Cryo-Cell International (CCEL) in Q1 2026, closing a stake of 105 shares.

Royal Bank of Canada first reported a position in CCEL in Q2 2022 and held it in 8 quarters. The position peaked at $13K in Q2 2022. 11 funds tracked by Wall St. Rank hold CCEL as of Q1 2026.

  • Royal Bank of Canada reported no remaining Cryo-Cell International position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 105 Cryo-Cell International shares in Q1 2026.
  • Royal Bank of Canada first reported a position in Cryo-Cell International in Q2 2022 and held it in 8 quarters.
  • Royal Bank of Canada's Cryo-Cell International position peaked at $13K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.